BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36497251)

  • 1. Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to
    Laot L; Sonigo C; Nobre J; Benachi A; Dervin T; El Moujahed L; Mayeur A; Stoppa-Lyonnet D; Steffann J; Grynberg M
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience.
    Dervin T; Ranisavjevic N; Laot L; Mayeur A; Duperier C; Steffann J; Borghese R; Stoppa-Lyonnet D; Frydman N; Benachi A; Sonigo C; Grynberg M
    J Assist Reprod Genet; 2023 Jun; 40(6):1381-1390. PubMed ID: 37154838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in
    El Moujahed L; Philis R; Grynberg M; Laot L; Mur P; Amsellem N; Mayeur A; Benoit A; Rakrouki S; Sifer C; Peigné M; Sonigo C
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765851
    [No Abstract]   [Full Text] [Related]  

  • 4. Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants.
    Vuković P; Peccatori FA; Massarotti C; Miralles MS; Beketić-Orešković L; Lambertini M
    Crit Rev Oncol Hematol; 2021 Jan; 157():103201. PubMed ID: 33333149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Breast Cancer and Germline BRCA Pathogenic Variants on Fertility Preservation in Young Women.
    Prokurotaite E; Condorelli M; Dechene J; Bouziotis J; Lambertini M; Demeestere I
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
    Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
    Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome?
    Sonigo C; Mayeur A; Sadoun M; Pinto M; Benguigui J; Frydman N; Monnot S; Benachi A; Steffann J; Grynberg M
    Hum Reprod; 2021 Oct; 36(11):3003-3013. PubMed ID: 34568938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of preimplantation genetic testing for aneuploidy in medically indicated fertility preservation.
    Blakemore JK; Trawick EC; Grifo JA; Goldman KN
    Fertil Steril; 2020 Feb; 113(2):408-416. PubMed ID: 31973902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility preservation in BRCA-mutated women: when and how?
    Grynberg M; Raad J; Comtet M; Vinolas C; Cédrin-Durnerin I; Sonigo C
    Future Oncol; 2018 Feb; 14(5):483-490. PubMed ID: 29327596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility in BRCA mutation carriers: counseling BRCA-mutated patients on reproductive issues.
    Knabben L; Siegenthaler F; Imboden S; Mueller MD
    Horm Mol Biol Clin Investig; 2020 Oct; 43(2):171-177. PubMed ID: 33027047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility preservation in BRCA mutation carriers-efficacy and safety issues: a review.
    Zhang X; Niu J; Che T; Zhu Y; Zhang H; Qu J
    Reprod Biol Endocrinol; 2020 Feb; 18(1):11. PubMed ID: 32070378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
    Peccatori FA; Mangili G; Bergamini A; Filippi F; Martinelli F; Ferrari F; Noli S; Rabaiotti E; Candiani M; Somigliana E
    Hum Reprod; 2018 Feb; 33(2):181-187. PubMed ID: 29207007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parameters of poor prognosis in preimplantation genetic testing for monogenic disorders.
    Van Der Kelen A; Santos-Ribeiro S; De Vos A; Verdyck P; De Rycke M; Berckmoes V; Tournaye H; Blockeel C; De Vos M; Hes FJ; Keymolen K; Verpoest W
    Hum Reprod; 2021 Aug; 36(9):2558-2566. PubMed ID: 34142115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.
    Michaan N; Leshno M; Cohen Y; Safra T; Peleg-Hasson S; Laskov I; Grisaru D
    Reprod Biol Endocrinol; 2021 Oct; 19(1):153. PubMed ID: 34620184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preimplantation genetic testing for aneuploidy in poor ovarian responders with four or fewer oocytes retrieved.
    Deng J; Hong HY; Zhao Q; Nadgauda A; Ashrafian S; Behr B; Lathi RB
    J Assist Reprod Genet; 2020 May; 37(5):1147-1154. PubMed ID: 32285297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive issues in carriers of germline pathogenic variants in the BRCA1/2 genes: an expert meeting.
    Buonomo B; Massarotti C; Dellino M; Anserini P; Ferrari A; Campanella M; Magnotti M; De Stefano C; Peccatori FA; Lambertini M
    BMC Med; 2021 Sep; 19(1):205. PubMed ID: 34503502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of BRCA mutation carriers' knowledge about the clinical impact of prophylactic-oophorectomy and views on fertility consultation: a single-center pilot study.
    Kim J; Skrzynia C; Mersereau JE
    J Genet Couns; 2015 Feb; 24(1):149-57. PubMed ID: 25120035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
    Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
    Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.